|5.||Breast Neoplasms (Breast Cancer)
|1.||Mantzoros, Christos S: 19 articles (11/2014 - 03/2002)|
|2.||Misra, Madhusmita: 10 articles (07/2015 - 12/2004)|
|3.||Check, J H: 9 articles (04/2014 - 01/2004)|
|4.||De Souza, Mary Jane: 9 articles (04/2011 - 02/2005)|
|5.||Klibanski, Anne: 8 articles (09/2014 - 12/2004)|
|6.||Miller, Karen K: 8 articles (10/2011 - 08/2004)|
|7.||Warren, Michelle P: 7 articles (07/2008 - 06/2002)|
|8.||Partridge, Ann H: 6 articles (06/2015 - 12/2007)|
|9.||Bouchard, Philippe: 6 articles (11/2013 - 09/2007)|
|10.||Meczekalski, Blazej: 6 articles (09/2013 - 05/2006)|
|1.||Gonadotropin-Releasing Hormone (GnRH)FDA Link
07/01/1995 - "The LH increase with GnRH was significantly greater in the breast-feeding group than in the hypothalamic amenorrhea group (19.75 mIU/mL vs. 12.34 mIU/mL, P < 0.05). "
03/01/1983 - " Clinical research has shown promising results in the induction of ovulation using the pulsatile pattern of GnRH administration in patients with hypogonadotropic amenorrhea. "
09/01/1997 - "To evaluate, in a pilot study, the use and efficacy of a gonadotropin-releasing hormone (GnRH)-agonist in inducing amenorrhea in women undergoing BMT. "
10/01/1986 - "The efficacy of ovulation induction with the use of intermittent gonadotropin-releasing hormone (GnRH) therapy was examined in seven infertile women with hypothalamic amenorrhea. "
08/01/1986 - "The efficacy of iv and sc chronic GnRH administration with different pulsatile patterns (15 micrograms every 90 min and 7.8 micrograms every 90 min with minor intermediate pulses of 2.3 micrograms every 22.2 min) by means of portable pumps were evaluated in a patient with primary hypothalamic amenorrhea. "
|2.||Estrogens (Estrogen)FDA Link
07/01/1999 - "Amenorrhea was induced early in a high percentage of women using 10-cm2 patches and oral HRT, and these therapies seemed to be convenient, effective, and safe for estrogen deficiency symptoms in postmenopausal women."
06/03/2010 - "Overall survival was improved in patients with amenorrhea for 6 months or more across all treatment groups, independently of estrogen-receptor status. "
09/01/1996 - "We conclude that amenorrhea is a cause of bone loss in young women and that estrogen therapy is effective in preventing bone loss."
06/03/2010 - "Amenorrhea was associated with improved survival regardless of the treatment and estrogen-receptor status. "
11/09/2012 - "PvuII and XbaI polymorphisms of estrogen receptor-α and the results of estroprogestagen therapy in girls with functional hypothalamic amenorrhea - preliminary study."
|3.||Bromocriptine (Parlodel)FDA LinkGeneric
01/01/1987 - "Bromocriptine therapy was effective in 54 of 84 cases (64%), including 6 of 15 (40%) cases with amenorrhea, 16 of 24 cases (67%) with anovulatory cycle, 9 of 15 cases (60%) with delayed ovulation and 23 of 30 cases (77%) with luteal phase defect. "
01/01/2000 - "Bromocriptine improves hyperprolactinemic amenorrhea and so could also be helpful in the treatment of unexplained subfertility in women. "
01/01/1996 - "Bromocriptine improves hyperprolactinemic amenorrhea and so could also be helpful in the treatment of unexplained subfertility in women. "
01/01/1981 - "Partial remission of hyperprolactinemic amenorrhea after bromocriptine-induced pregnancy."
01/01/1984 - "Controlled study of bromocriptine and placebo for induction of ovulation in normoprolactinemic secondary amenorrhea."
05/01/1996 - "Programmatic findings suggest that studies be conducted of the contribution of extended LAM to improved weaning practices, the high efficacy of continued reliance on substantial lactation and amenorrhea beyond nine months, and male involvement in LAM and breastfeeding."
12/01/1991 - " Now that more women are breastfeeding, and lactational amenorrhea is being studied worldwide, it is recognized that LAM is about 98% effective for the 1st 6 months postpartum in fully breastfeeding women. "
11/01/2000 - "The purpose of this study was to assess the efficacy of the lactational amenorrhea method (LAM) for family planning among mothers who are separated from their infants by work. "
11/01/2000 - "The objective of this effort was to assess the use and efficacy of the Lactational Amenorrhea Method (LAM) with reduced numbers of client-provider contacts. "
11/01/2000 - "The efficacy of the lactational amenorrhea method (LAM) among working women."
|5.||Clomiphene (Clomifene)FDA LinkGeneric
06/01/2007 - "To determine if a new protocol of administration of clomiphene citrate (CC) is effective in menstrual cycle recovery in women with hypothalamic secondary amenorrhea. "
03/01/1994 - "The efficacy of long term consecutive treatment of clomiphene citrate (CC) was investigated in 608 infertile women associated with anovulatory disorders (classified as WHO group II amenorrhea). "
12/01/1987 - "The study group consisted of 10 women (26 to 38 years of age) with secondary amenorrhea as a result of hypothalamic dysfunction who had failed to ovulate when given clomiphene citrate. "
03/01/1987 - "The purpose of this study is to investigate the ovulatory effect of the following three methods on 40 patients with normoprolactinemic amenorrhea patients who failed to respond to clomiphene citrate (Cl) alone. "
09/01/1968 - "Pituitary-function studies performed before treating secondary amenorrhea with clomiphene citrate. "
|6.||Mifepristone (RU 486)FDA Link
07/01/1995 - " The 12 studies, conducted in Sweden, England, Hong Kong, Scotland, Denmark, France, and the US, differed in terms of clinical regimen (RU-486 alone or in combination with a prostaglandin suppository), sample size (range, 18-251), duration of amenorrhea (maximum, 63 days), and patient allocation (random or patient choice). "
01/01/1989 - "Four multicentre clinical trials on interruption of early pregnancy (less than or equal to 49 days of amenorrhea) using RU 486 have been conducted in China, including 2321 subjects. "
01/01/2015 - "At inclusion time, when women were given mifepristone, the mean term of pregnancy was 46.5 ± 7.8 days of amenorrhea (DA), the term was >49 DA for 28.3% of patients, and >63 DA for 1.6%. "
01/01/2013 - "Amenorrhea was 93.1% and 4.3% in the mifepristone and placebo groups, respectively (P < 0.001). "
10/01/2000 - "In non-human primates, PAs, including mifepristone, ZK 137 316 and ZK 230 211, inhibit endometrial proliferation and induce amenorrhea. "
09/01/2002 - "To study the characteristics of low bone mass in amenorrhea patients with elevated follicular stimulating hormone (FSH). "
01/01/2001 - "Seventy-three patients with secondary hypergonadotropic amenorrhea and, as control group, 144 women with acute, non-gynecological, non-neoplastic, non-hormone-related diseases were included in the study. "
01/01/1954 - "[Further study of genital hormone conditions in lactation amenorrhea]."
08/01/2014 - "Amenorrhea secondary to a vismodegib-induced blockade of follicle-stimulating hormone-receptor activation."
01/01/2014 - "Genetic background, ineffectiveness of appetite regulating hormones on refeeding process, bone loss, and place of amenorrhea in the definition are widely discussed and reviewed. "
05/01/1965 - "[Studies with a new drug with a progesterone base, in the differential diagnosis of pregnancy and secondary amenorrhea]."
04/01/1946 - "Studies on high dosage progesterone therapy of amenorrhea."
01/01/2006 - "In hypergonadotropic women with amenorrhea was found positive correlation between progesterone and HDL (P=0.043). "
01/01/2004 - "These functional abnormalities, which occur along a continuum from mild, luteal phase progesterone deficiency to amenorrhea, are relatively common and are often attributed to psychogenic factors (stress, anxiety, depression, or other emotional disturbance), exercise, or energy imbalance. "
03/01/1997 - "Progesterone level was also significantly lower in the patients with amenorrhea and irregular cycle (0.01) and it was significantly raised in the patients with regular cycle (p < 0.05). "
11/01/1977 - " The prolactin assay is helpful in the management of patients with amenorrhea."
01/01/1991 - "Within the study group, results were independent of prolactin (HPRL) levels or amenorrhea."
04/02/1983 - "This study investigated prospectively the effect of supplementary breastfeeding on the duration of lactational amenorrhea and serum prolactin levels during prolonged breastfeeding in a group of 34 Australian mothers. "
11/01/1977 - "[Value of the radioimmunoassay of FSH, LH and prolactin in the pathogenetic study of secondary amenorrhea]."
11/01/2015 - "An otherwise healthy 27-year-old woman presented with secondary amenorrhea and moderately elevated prolactin levels. "
|10.||Misoprostol (Cytotec)FDA LinkGeneric
11/01/2005 - "We are reporting the case of a woman with 8 weeks of amenorrhea who orally received a single dose of misoprostol 400 microg at midnight for ripening of cervix before uterine evacuation of an intrauterine gestational sac containing a single fetus (6.3 weeks of gestation) without cardiac activity. "
02/01/2004 - "Thirty-two first-time-pregnant women with 8-12 weeks amenorrhea were randomly assigned to receive 400 microg misoprostol either orally or sublingually 3 h prior to surgery. "
01/01/2000 - "Women with < or =42 days of amenorrhea, pregnancy confirmed by ultrasound, and approved request for termination received 800 microg of vaginal misoprostol once and were observed for 1 week. "
04/01/1996 - "Two doses, 200 and 400 micrograms, of misoprostol, administered vaginally every 12 hours, up to four times, were tested in 101 and 133 healthy women, respectively, for interruption of pregnancies with 35 through 77 days of amenorrhea. "
01/01/1996 - "One hundred and twenty nine nulliparous requesting first trimester induced abortion between 7 and 12 weeks of amenorrhea (SA) were included in the study to evaluate the effectiveness and the side effects of misoprostol in the cervical ripening before aspiration. "
|1.||Drug Therapy (Chemotherapy)
07/01/2015 - "Studies have demonstrated that women who experience cessation of ovarian function after chemotherapy (chemotherapy-induced amenorrhea) may experience improved survival. "
12/01/2015 - "In eight studies reporting amenorrhea rates 1 year after chemotherapy completion, the addition of LHRHa reduced the risk of POF (OR 0.55, 95% CI 0.41-0.73, P < 0.001) without heterogeneity (I(2) = 0.0%, Pheterogeneity = 0.936). "
12/01/2015 - "POF by study definition, and POF defined as amenorrhea 1 year after chemotherapy completion) and for patients with pregnancy, as well hazard ratios (HRs) and 95% CI for DFS, were calculated for each trial. "
11/01/2002 - "Whether chemotherapy-induced amenorrhea has a prognostic effect remains unclear, and further studies are warranted."
12/01/1987 - "Beneficial effects of chemotherapy induced amenorrhea was noted in four of five reported adjunctive trials. "
|2.||Contraception (Birth Control)
01/01/2013 - "The purpose of this study was to assess the attitudes and prescribing practices of Brazilian obstetricians and gynecologists regarding use of contraceptive methods to interfere with menstruation and/or induce amenorrhea. "
06/01/2012 - "This study was conducted to evaluate bone mineral density (BMD) changes during postpartum period among healthy women and its association with breastfeeding, use of contraceptive methods, amenorrhea and body mass index (BMI). "
02/01/2009 - "This study confirms the results of other studies concerning the effectiveness of the lactational amenorrhea method as a natural method of contraception for the first 6 months postpartum, especially for mothers who breast-feed exclusively and more frequently and who delay the introduction of food supplements."
01/01/2003 - "Amenorrhea associated with contraception-an international study on acceptability."
01/01/2000 - "Our studies show advantages for protection of the endometrium, for contraception and a high amenorrhea rate. "
|3.||Endometrial Ablation Techniques
01/01/2014 - "In randomized controlled trials with other global endometrial ablation modalities, amenorrhea rates at 12 months with the NovaSure procedure ranged from 43.0% to 56.0%, while other modalities ranged from 8% to 24%. "
10/01/2006 - "All have been compared with rollerball endometrial ablation by way of randomized clinical trials and are associated with high patient satisfaction rates, regardless of method, but a wide range of amenorrhea rates (13.9-55.3%). "
01/01/2015 - "In women with DUB, endometrial ablation with Novasure bipolar radiofrequency impedance-controlled system is associated with increased rates of amenorrhea at 12-months post-treatment as compared to the MEA method."
01/01/2014 - "This review examines the peer-reviewed literature describing prospective studies that report amenorrhea rates, patient satisfaction, and surgical reintervention rates following the NovaSure® endometrial ablation procedure. "
11/01/2011 - "Women with and without a history of cesarean delivery had comparable rates for 5 year cumulative endometrial ablation failure, amenorrhea, treatment failure, and operative complications. "
|4.||Hormone Replacement Therapy (Therapy, Hormone Replacement)
05/01/2001 - "Endometrial thickness may help to predict the chance of achieving amenorrhea during early hormone replacement therapy."
10/01/2003 - "Thirty menopausal women on hormone replacement therapy and 32 menopausal women who had never received hormone replacement therapy (HRT), matched for age and duration of amenorrhea, participated in this study. "
10/01/2013 - "All three patients developed secondary amenorrhea following HPV vaccinations, which did not resolve upon treatment with hormone replacement therapies. "
04/01/2010 - "A Case of amenorrhea in female athletes, it is necessary to consider the hormone replacement therapy based on the appropriate diagnosis. "
04/01/2009 - "Patients were diagnosed at the first appointment according to menstrual cycle over the past year: Amenorrhea (AM), Oligo-amenorrhea (OL-AM), OL, Taking hormone replacement therapy (HRT). "
|5.||Natural Family Planning Methods (Natural Family Planning)
12/01/1991 - "The efficacy of the symptothermal method of natural family planning (NFP), in the 1st 3 cycles after cessation of postpartum lactational amenorrhea was assessed in 25 women. "
07/01/2010 - "To assess physicians' knowledge, attitudes, and practice with respect to four evidence-based natural family planning (NFP) methods: Standard Days, cervical mucus, basal body temperature, and the lactational amenorrhea method. "
03/01/2001 - "Nurse-midwives' knowledge and promotion of lactational amenorrhea and other natural family-planning methods for child spacing."
05/24/1996 - "A prospective study conducted among clients attending New Zealand Association of Natural Family Planning clinics confirmed that lactational amenorrhea is an effective means of avoiding pregnancy in the first 6 months postpartum. "
12/01/1991 - "Using the lactational amenorrhea method rather than natural family planning allows them to avoid unnecessary abstinence."